Targeted
 Protein
Degradation

Our Science

SNIPER: Specific and Non-genetic IAP-dependent Protein ERaser

IAPs are frequently overexpressed in tumor cells,
which is involved in resistance to tumor therapy

Company Overview

Name
UBiENCE Inc.
Address
8F Nihonbashi Life Science Building7 1-9-10 Nihonbashi-horidomecho, Chuo-ku, Tokyo 103-0012, JAPAN
Business Summary
Discovery and Development of Pharmaceutical Compounds
Established
April 20, 2018
Capitalization
227,320,000Yen
Employees
3
URL
https://www.ubience.com/
Fiscal Year
December
Board of Directors

President Yasuhiro IWATA

Director Nobuyuki TAKAHASHI

Director, Co-founder Hirobumi TAKEUCHI

Company Auditors
Atsuko SUYAMA